Labeling may differ between generic, brand-name products

被引：2
|
作者：
Traynor, K
机构：
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2002年 / 59卷 / 10期
关键词：
D O I：
10.1093/ajhp/59.10.912
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：912 / +
页数：2
相关论文
共 50 条
  • [1] Investigation of Bioequivalence Between Brand-name and Generic Irinotecan Products
    Saito, Ken-Ichi
    Inoue, Yutaka
    Ikegami, Yoji
    Nanbo, Izumi
    Onozuka, Mari
    Sano, Kazumi
    Yoshida, Hisahiro
    Sakamoto, Toshihiro
    Tatebayashi, Emi
    Fujita, Ken-Ichi
    Sasaki, Yasutsuna
    Kitazawa, Takaki
    [J]. ANTICANCER RESEARCH, 2016, 36 (11) : 5957 - 5963
  • [2] Equivalence of generic and brand-name ophthalmic products
    Fiscella, RG
    Gaynes, BI
    Jensen, M
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (07) : 616 - 617
  • [3] A brand-name generic
    Savage, PR
    [J]. IEEE SPECTRUM, 2004, 41 (10) : 60 - 61
  • [4] Brand-name and generic antiepileptics
    Hussar, Daniel A.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (18) : 1608 - 1608
  • [5] Brand-name versus generic
    Copeland, Kennon R.
    Boccuzzi, Stephen J.
    [J]. HEALTH AFFAIRS, 2007, 26 (04) : 1198 - 1199
  • [6] Generic versus brand-name medicinal products: Are they really interchangeable?
    Motola, D.
    De Ponti, F.
    [J]. DIGESTIVE AND LIVER DISEASE, 2006, 38 (08) : 560 - 562
  • [7] Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism
    Dong, BJ
    Hauck, WW
    Gambertoglio, JG
    Gee, L
    White, JR
    Bubp, JL
    Greenspan, FS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (15): : 1205 - 1213
  • [8] Brand-Name Versus Generic Drugs
    Manning, Richard
    Smith, Richard
    [J]. HEALTH AFFAIRS, 2011, 30 (10) : 2027 - 2027
  • [9] Are brand-name and generic warfarin interchangeable?
    Pereira, JA
    Holbrook, AM
    Dolovich, L
    Douketis, JD
    Crowther, MA
    Bates, SM
    Ginsberg, JR
    Goldsmith, C
    Thabane, L
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P27 - P27
  • [10] Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers
    Jacinthe Leclerc
    Claudia Blais
    Louis Rochette
    Denis Hamel
    Line Guénette
    Claudia Beaudoin
    Paul Poirier
    [J]. Drugs in R&D, 2020, 20 : 135 - 145
12345